Pediatric Gastroenterology and Nutrition Unit, Centro Hospitalar e Universitario de Coimbra EPE Hospital Pediátrico de Coimbra, Coimbra, Portugal
Clínica Universitária de Pediatria, Universidade de Coimbra Faculdade de Medicina, Coimbra, Portugal.
BMJ Paediatr Open. 2022 Apr;6(1). doi: 10.1136/bmjpo-2022-001422.
To analyse the association of faecal calprotectin with the genetic and clinical characteristics of paediatric patients with cystic fibrosis (PwCF). In a subset of these patients, we aimed to associate histological inflammatory features of rectal mucosa to faecal calprotectin levels.
In a prospective study, faecal calprotectin levels were collected in all 23 PwCF attending our paediatric centre, together with demographic and clinical data. Associations between faecal calprotectin and clinical features were determined. In 11 of these patients, endoscopic rectal biopsies were obtained and the association between faecal calprotectin and histological inflammatory markers was analysed. Statistical analyses included Spearman's correlation coefficient, Mann-Whitney U test and Fisher's exact test. Sensitivity and specificity was calculated.
Median age of PwCF was 12 years, 19 had pancreatic insufficiency (PI) (19/23). Seventeen (17/23) had elevated faecal calprotectin, and the median value was 88 µg/g (IQR=178 µg/g). Higher faecal calprotectin levels were observed in the PI group (101 vs 30 µg/g, p=0.027). No significant correlation between elevated faecal calprotectin level and body mass index z-score was found. Five patients (22%) reported abdominal pain, three (13%) complained of diarrhoea and three (13%) had constipation, but these symptoms were not associated with elevated faecal calprotectin.Unspecific focal rectal inflammation was found in four patients (4/11). An association between rectal mucosa inflammation and elevated faecal calprotectin was found (p=0.015). Sensitivity was 100% and specificity was 86%.
In our PwCF, elevated faecal calprotectin was frequent, particularly if PI, and it was not related to gastrointestinal symptoms or malnutrition. Elevated faecal calprotectin was present in patients with histological evidence of rectal inflammation. Faecal calprotectin may be an indicator of asymptomatic rectal inflammation in PwCF.
分析粪便钙卫蛋白与囊性纤维化(PwCF)儿科患者的遗传和临床特征之间的关联。在这些患者的一个亚组中,我们旨在将直肠黏膜的组织学炎症特征与粪便钙卫蛋白水平相关联。
在一项前瞻性研究中,收集了所有 23 名就诊于我们儿科中心的 PwCF 的粪便钙卫蛋白水平,同时收集了人口统计学和临床数据。确定粪便钙卫蛋白与临床特征之间的关联。在其中 11 名患者中,获得了内镜直肠活检,并分析了粪便钙卫蛋白与组织学炎症标志物之间的关联。统计分析包括 Spearman 相关系数、Mann-Whitney U 检验和 Fisher 确切检验。计算了灵敏度和特异性。
PwCF 的中位年龄为 12 岁,19 名患者有胰腺功能不全(PI)(19/23)。17 名(17/23)患者粪便钙卫蛋白升高,中位数为 88µg/g(IQR=178µg/g)。PI 组的粪便钙卫蛋白水平更高(101 与 30µg/g,p=0.027)。未发现粪便钙卫蛋白升高水平与体重指数 z 评分之间存在显著相关性。有 5 名患者(22%)报告腹痛,3 名(13%)抱怨腹泻,3 名(13%)有便秘,但这些症状与粪便钙卫蛋白升高无关。4 名患者(4/11)存在非特异性局灶性直肠炎症。发现直肠黏膜炎症与粪便钙卫蛋白升高之间存在关联(p=0.015)。灵敏度为 100%,特异性为 86%。
在我们的 PwCF 中,粪便钙卫蛋白升高很常见,特别是如果存在 PI,则与胃肠道症状或营养不良无关。在有直肠炎症组织学证据的患者中存在粪便钙卫蛋白升高。粪便钙卫蛋白可能是 PwCF 无症状直肠炎症的一个指标。